OCM
Osterweis Capital Management’s Thermo Fisher Scientific TMO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $14.2K | Sell |
35
-77,420
| -100% | -$31.4M | ﹤0.01% | 270 |
|
|
2025
Q1 | $38.5M | Buy |
77,455
+13,169
| +20% | +$6.55M | 1.9% | 14 |
|
|
2024
Q4 | $33.4M | Buy |
64,286
+1,419
| +2% | +$738K | 1.56% | 21 |
|
|
2024
Q3 | $38.9M | Buy |
62,867
+8,582
| +16% | +$5.31M | 1.97% | 12 |
|
|
2024
Q2 | $30M | Buy |
54,285
+571
| +1% | +$316K | 1.55% | 24 |
|
|
2024
Q1 | $31.2M | Sell |
53,714
-682
| -1% | -$396K | 1.83% | 21 |
|
|
2023
Q4 | $28.9M | Buy |
54,396
+53,396
| +5,340% | +$28.3M | 1.83% | 22 |
|
|
2023
Q3 | $506K | Hold |
1,000
| – | – | 0.04% | 109 |
|
|
2023
Q2 | $522K | Sell |
1,000
-47
| -4% | -$24.5K | 0.03% | 114 |
|
|
2023
Q1 | $603K | Hold |
1,047
| – | – | 0.04% | 111 |
|
|
2022
Q4 | $577K | Buy |
1,047
+62
| +6% | +$34.1K | 0.04% | 113 |
|
|
2022
Q3 | $500K | Hold |
985
| – | – | 0.04% | 112 |
|
|
2022
Q2 | $535K | Sell |
985
-35
| -3% | -$19K | 0.04% | 115 |
|
|
2022
Q1 | $602K | Hold |
1,020
| – | – | 0.03% | 120 |
|
|
2021
Q4 | $681K | Hold |
1,020
| – | – | 0.03% | 117 |
|
|
2021
Q3 | $583K | Hold |
1,020
| – | – | 0.03% | 117 |
|
|
2021
Q2 | $515K | Hold |
1,020
| – | – | 0.03% | 119 |
|
|
2021
Q1 | $466K | Hold |
1,020
| – | – | 0.03% | 114 |
|
|
2020
Q4 | $475K | Buy |
+1,020
| New | +$475K | 0.03% | 104 |
|
|
2020
Q1 | – | Sell |
-625
| Closed | -$203K | – | 124 |
|
|
2019
Q4 | $203K | Buy |
+625
| New | +$203K | 0.01% | 111 |
|